Bank Of America Corp Graybug Vision, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.46 - $1.05 $20 - $46	44 New	44 $0
Q1 2022 May 16, 2022	SELL	$1.13 - $1.93 $125 - $214	-111 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$1.74 - $3.6 $193 - $399	111 New	111 $0
Q3 2021 Nov 15, 2021	SELL	$3.18 - $5.17 $3,882 - $6,312	-1,221 Closed	0 $0
Q2 2021 Sep 13, 2021	BUY	$3.53 - $6.1 $4,310 - $7,448	1,221 New	1,221 $7,000

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.